211 related articles for article (PubMed ID: 32443344)
1. Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
Chen C; Ke R; Yang F; Cai Q; Liu J; Huang X; Chen J; Xu F; Jiang Y
Medicine (Baltimore); 2020 May; 99(20):e20205. PubMed ID: 32443344
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
Steenstraten IC; Sebib Korkmaz K; Trivedi PJ; Inderson A; van Hoek B; Rodriguez Girondo MDM; Maljaars PWJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):636-643. PubMed ID: 30740723
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
Tanaka A; Kono H; Leung PSC; Gershwin ME
Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Montano-Loza AJ; Bhanji RA; Wasilenko S; Mason AL
Aliment Pharmacol Ther; 2017 Feb; 45(4):485-500. PubMed ID: 27957759
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
Åberg F; Sallinen V; Tuominen S; Adam R; Karam V; Mirza D; Heneghan MA; Line PD; Bennet W; Ericzon BG; Grat M; Lodge P; Rasmussen A; Schmelzle M; Thorburn D; Fondevila C; Helanterä I; Nordin A;
J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of liver transplantation in autoimmune liver diseases.
Zhong CP; Xi ZF; Xia Q
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
Duclos-Vallée JC
Acta Gastroenterol Belg; 2005; 68(3):331-6. PubMed ID: 16268420
[TBL] [Abstract][Full Text] [Related]
8. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
[TBL] [Abstract][Full Text] [Related]
9. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.
Montano-Loza AJ; Ronca V; Ebadi M; Hansen BE; Hirschfield G; Elwir S; Alsaed M; Milkiewicz P; Janik MK; Marschall HU; Burza MA; Efe C; Calışkan AR; Harputluoglu M; Kabaçam G; Terrabuio D; de Quadros Onofrio F; Selzner N; Bonder A; Parés A; Llovet L; Akyıldız M; Arikan C; Manns MP; Taubert R; Weber AL; Schiano TD; Haydel B; Czubkowski P; Socha P; Ołdak N; Akamatsu N; Tanaka A; Levy C; Martin EF; Goel A; Sedki M; Jankowska I; Ikegami T; Rodriguez M; Sterneck M; Weiler-Normann C; Schramm C; Donato MF; Lohse A; Andrade RJ; Patwardhan VR; van Hoek B; Biewenga M; Kremer AE; Ueda Y; Deneau M; Pedersen M; Mayo MJ; Floreani A; Burra P; Secchi MF; Beretta-Piccoli BT; Sciveres M; Maggiore G; Jafri SM; Debray D; Girard M; Lacaille F; Lytvyak E; Mason AL; Heneghan M; Oo YH;
J Hepatol; 2022 Jul; 77(1):84-97. PubMed ID: 35143897
[TBL] [Abstract][Full Text] [Related]
11. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
Visseren T; Darwish Murad S
Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of inflammatory bowel disease in the organ recipient.
Indriolo A; Ravelli P
World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
[TBL] [Abstract][Full Text] [Related]
14. The immunoreactive patient: Rejection and autoimmune disease.
O'Grady J
Liver Transpl; 2011 Nov; 17 Suppl 3():S29-33. PubMed ID: 21850694
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
Liberal R; Vergani D; Mieli-Vergani G
Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune liver disease, autoimmunity and liver transplantation.
Carbone M; Neuberger JM
J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study.
Visseren T; Erler NS; Heimbach JK; Eaton JE; Selzner N; Gulamhusein A; van der Heide F; Porte RJ; van Hoek B; Alwayn IPJ; Metselaar HJ; IJzermans JNM; Darwish Murad S
JHEP Rep; 2022 Dec; 4(12):100599. PubMed ID: 36426376
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
[TBL] [Abstract][Full Text] [Related]
20. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]